RCMI Coordinating Center (RCMI CC) Header Logo

Carmen D. Zorrilla

Faculty RankProfessor
InstitutionUniversity of Puerto Rico
DepartmentSchool of Medicine
AddressUPR-Medical Sciences Campus
Maternal Infant Studies Center (CEMI)
San Juan PR 936
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    Area of Expertise: AIDS - VACCINE TRIALS., Zika
    I’m a Professor of Obstetrics and Gynecology at the UPR School of Medicine, certified by the American Board of Obstetrics and Gynecology and the American Academy of HIV Medicine. I have experience in both
    Obstetrics and Gynecology and HIV related research that includes behavioral interventions and clinical trials with HIV infected and at risk populations, as well as with pregnant and non-pregnant women. I was part of the group of examiners for the American Oral Board of Ob-Gyn (ABOG) for 22 years and Past Residency Program Director for the UPR Ob-Gyn program. I established an infrastructure for the care of pregnant and non-pregnant women. The transmission rate of HIV infection among the more than 500 infants born to pregnant women living with HIV during the past 13 years at our clinic has been near zero. I’m currently the PI of the UPR Clinical Trials Unit (UPR-CTU), a merge of clinical trials units including the Pediatric AIDS Clinical Trials Unit (IMPAACT), the Adult Clinical Trials Unit (ACTG) and the UPR Mentoring Institute for HIV and Mental Health sponsored by NIMH. I have been a consultant for diverse national and international organizations including the National Institutes of Health (NIH), the Maternal and Child Health Bureau (MCHB), the Centers for Disease Control (CDC), the Agency for Health Research Quality (AHRQ) and others, and a former member of the Office of Women’s Health Advisory Committee and the CDC/HRSA AIDS and STD Advisory Committee (CHAC). Some of the distinctions that I have received include: PR Senate resolution and Distinction (1990), UPR President’s Recognition (2000); listed in the 30 people to watch by POZ Magazine; the AMSA Raising Our Voices: Women Leaders in Medicine Award and a distinction from the PR HIV Treaters Association. We established the first group prenatal care program in PR (Centering Pregnancy) with funds from the Innovation Center of the Centers for Medicare & Medicaid Services (CMS). This is the first Spanish Centering Program outside of the Mainland US. One of the outcomes of the program has been the reduction in preterm births and low birth weight among infants born of women enrolled in group prenatal care at the University Hospital. Expanding the program in order to impact and improve the health of mothers and infants is also one of my professional goals. I’m part of the group of leaders who spearheaded the research response to the emerging Zika epidemic among pregnant women in PR. We also established a multidisciplinary clinic for pregnant women with Zika. I’m the site PI for the Zika in Infants and Pregnancy (ZIP Study) in San Juan. On September 20, 2017 Puerto Rico was impacted by Hurricane Maria (Category 4) which devastated the island and produced a collapse in the Island’s power system. Because of this, water, health services, education, economy, fuel distribution and essential services were interrupted. I had the opportunity to write a perspective article in the NEJM describing our initial experience.

    Collapse Featured Content 
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Zorrilla CD, Rodríguez-Figueroa L, Miranda-De León S, López-Alvarado B, Pérez E, Rabionet SE. Elimination of the Perinatal Transmission of HIV and Syphilis in Puerto Rico and Sustained Success since 2007: Convergence of Science, Women-Centered Care, and Policy. P R Health Sci J. 2021 Mar; 40(1):12-18. PMID: 33876913.
      Citations:    Fields:    
    2. Haas DW, Cramer YS, Godfrey C, Rosenkranz SL, Aweeka F, Berzins B, Coombs R, Coughlin K, Moran LE, Gingrich D, Zorrilla CD, Baker P, Cohn SE, Scarsi KK. Pharmacogenetic interactions between antiretroviral drugs and vaginally administered hormonal contraceptives. Pharmacogenet Genomics. 2020 04; 30(3):45-53. PMID: 32106141.
      Citations: 1     Fields:    Translation:Humans
    3. Lebov JF, Arias JF, Balmaseda A, Britt W, Cordero JF, Galvão LA, Garces AL, Hambidge KM, Harris E, Ko A, Krebs N, Marques ETA, Martinez AM, McClure E, Miranda-Filho DB, Moreira MEL, Mussi-Pinhata MM, Ochoa TJ, Osorio JE, Scalabrin DMF, Schultz-Cherry S, Seage GR, Stolka K, Ugarte-Gil CA, Vega CMV, Welton M, Ximenes R, Zorrilla C. Correction to: International prospective observational cohort study of Zika in infants and pregnancy (ZIP study): study protocol. BMC Pregnancy Childbirth. 2019 Nov 19; 19(1):423. PMID: 31744466.
      Citations:    Fields:    
    4. Valdes V, Zorrilla CD, Gabard-Durnam L, Muler-Mendez N, Rahman ZI, Rivera D, Nelson CA. Cognitive Development of Infants Exposed to the Zika Virus in Puerto Rico. JAMA Netw Open. 2019 10 02; 2(10):e1914061. PMID: 31651970.
      Citations: 6     Fields:    Translation:Humans
    5. Scarsi KK, Cramer YS, Rosenkranz SL, Aweeka F, Berzins B, Coombs RW, Coughlin K, Moran LE, Zorrilla CD, Akelo V, Aziz M, Friedman RK, Gingrich D, Swaminathan S, Godfrey C, Cohn SE. Antiretroviral therapy and vaginally administered contraceptive hormones: a three-arm, pharmacokinetic study. Lancet HIV. 2019 09; 6(9):e601-e612. PMID: 31498109.
      Citations: 2     Fields:    Translation:HumansCellsCTClinical Trials
    6. Liu AY, Norwood A, Gundacker H, Carballo-Diéguez A, Johnson S, Patterson K, Bekker LG, Chariyalertsak S, Chitwarakorn A, Gonzales P, Holtz TH, Mayer KH, Zorrilla C, Buchbinder S, Piper JM, Lama JR, Cranston RD. Brief Report: Routine Use of Oral PrEP in a Phase 2 Rectal Microbicide Study of Tenofovir Reduced-Glycerin 1% Gel (MTN-017). . 2019 08 15; 81(5):516-520. PMID: 31299013.
    7. Lebov JF, Arias JF, Balmaseda A, Britt W, Cordero JF, Galvão LA, Garces AL, Hambidge KM, Harris E, Ko A, Krebs N, Marques ETA, Martinez AM, McClure E, Miranda-Filho DB, Moreira MEL, Mussi-Pinhata MM, Ochoa TJ, Osorio JE, Scalabrin DMF, Schultz-Cherry S, Seage GR, Stolka K, Ugarte-Gil CA, Vega CMV, Welton M, Ximenes R, Zorrilla C. International prospective observational cohort study of Zika in infants and pregnancy (ZIP study): study protocol. BMC Pregnancy Childbirth. 2019 Aug 07; 19(1):282. PMID: 31391005.
      Citations: 6     Fields:    Translation:HumansCells
    8. Rabionet SE, Zorrilla CD, Rivera-Viñas JI, Guerra-Sanchez Y. Pregnancy and Zika: The Quest for Quality Care and Reproductive Justice. P R Health Sci J. 2018 12; 37(Spec Issue):S45-S50. PMID: 30576577.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    9. Zorrilla CD, Rivera-Viñas JI, De La Vega-Pujols A, Garcia-Garcia I, Rabionet SE, Mosquera AM. The Zika Virus Infection in Pregnancy: Review and Implications for Research and Care of Women and Infants in Affected Areas. P R Health Sci J. 2018 12; 37(Spec Issue):S66-S72. PMID: 30576580.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    10. Gely-Rojas L, García-Fragoso L, Negrón J, Deynes D, García-García I, Zorrilla CD. Congenital Zika Syndrome in Puerto Rico, Beyond Microcephaly, A Multiorgan Approach. P R Health Sci J. 2018 12; 37(Spec Issue):S73-S76. PMID: 30576581.
      Citations: 1     Fields:    Translation:Humans
    11. Figueroa-Cosme WI, Miranda-Díaz C, López-Córdova NM, Capriles JA, Velez CN, Santiago LE, Zorrilla C. The birds and the bees: do Puerto Rican mothers and daughters talk about sex? Arch Clin Med Case Rep. 2018; 2(6):190-205. PMID: 30984915.
    12. Zorrilla CD, Báez FR, Colón KG, Ibarra J, García I, Mosquera AM. HIV seroconversion during pregnancy and the need for pre-exposure prophylaxis (PrEP). HIV AIDS (Auckl). 2018; 10:57-61. PMID: 30804684.
    13. Osiyemi O, Yasin S, Zorrilla C, Bicer C, Hillewaert V, Brown K, Crauwels HM. Pharmacokinetics, Antiviral Activity, and Safety of Rilpivirine in Pregnant Women with HIV-1 Infection: Results of a Phase 3b, Multicenter, Open-Label Study. Infect Dis Ther. 2018 Mar; 7(1):147-159. PMID: 29335895.
    14. Zorrilla CD, García García I, García Fragoso L, De La Vega A. Zika Virus Infection in Pregnancy: Maternal, Fetal, and Neonatal Considerations. J Infect Dis. 2017 12 16; 216(suppl_10):S891-S896. PMID: 29267916.
      Citations: 15     Fields:    Translation:HumansCellsPHPublic Health
    15. Carballo-Diéguez A, Giguere R, Dolezal C, Leu CS, Balán IC, Brown W, Rael C, Richardson BA, Piper JM, Bekker LG, Chariyalertsak S, Chitwarakorn A, Gonzales P, Holtz TH, Liu A, Mayer KH, Zorrilla CD, Lama JR, McGowan I, Cranston RD. Preference of Oral Tenofovir Disoproxil Fumarate/Emtricitabine Versus Rectal Tenofovir Reduced-Glycerin 1% Gel Regimens for HIV Prevention Among Cisgender Men and Transgender Women Who Engage in Receptive Anal Intercourse with Men. AIDS Behav. 2017 Dec; 21(12):3336-3345. PMID: 29119473.
      Citations: 4     Fields:    Translation:HumansPHPublic Health
    16. Zorrilla CD. The View from Puerto Rico - Hurricane Maria and Its Aftermath. N Engl J Med. 2017 Nov 09; 377(19):1801-1803. PMID: 29019710.
      Citations: 12     Fields:    Translation:Humans
    17. Silva-Suárez G, Rabionet SE, Zorrilla CD. HIV normalization message and its implication on the lives of perinatally HIV-infected youth in Puerto Rico. J Pharm Health Serv Res. 2017 Dec; 8(4):241-246. PMID: 33042232.
    18. Carballo-Diéguez A, Balán IC, Brown W, Giguere R, Dolezal C, Leu CS, Marzinke MA, Hendrix CW, Piper JM, Richardson BA, Grossman C, Johnson S, Gomez K, Horn S, Kunjara Na Ayudhya RP, Patterson K, Jacobson C, Bekker LG, Chariyalertsak S, Chitwarakorn A, Gonzales P, Holtz TH, Liu A, Mayer KH, Zorrilla C, Lama J, McGowan I, Cranston RD. High levels of adherence to a rectal microbicide gel and to oral Pre-Exposure Prophylaxis (PrEP) achieved in MTN-017 among men who have sex with men (MSM) and transgender women. PLoS One. 2017; 12(7):e0181607. PMID: 28750059.
      Citations: 13     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    19. Cranston RD, Lama JR, Richardson BA, Carballo-Diéguez A, Kunjara Na Ayudhya RP, Liu K, Patterson KB, Leu CS, Galaska B, Jacobson CE, Parikh UM, Marzinke MA, Hendrix CW, Johnson S, Piper JM, Grossman C, Ho KS, Lucas J, Pickett J, Bekker LG, Chariyalertsak S, Chitwarakorn A, Gonzales P, Holtz TH, Liu AY, Mayer KH, Zorrilla C, Schwartz JL, Rooney J, McGowan I. MTN-017: A Rectal Phase 2 Extended Safety and Acceptability Study of Tenofovir Reduced-Glycerin 1% Gel. Clin Infect Dis. 2017 03 01; 64(5):614-620. PMID: 27986684.
      Citations: 17     Fields:    Translation:HumansCellsCTClinical Trials
    20. Zorrilla CD, Sánchez I, Mosquera AM, Sierra D, Pérez LAL, Rabionet S, Rivera-Viñas J. Improved Infant Outcomes with Group Prenatal Care in Puerto Rico. Source J Obstet Gynaecol. 2017; 1(1). PMID: 30159551.
    21. Zorrilla CD, Mosquera AM, Rabionet S, Rivera-Viñas J. HIV and ZIKA in Pregnancy: Parallel Stories and New Challenges. Obstet Gynecol Int J. 2016; 5(6). PMID: 28529970.
    22. Ramgopal M, Osiyemi O, Zorrilla C, Crauwels HM, Ryan R, Brown K, Hillewaert V, Baugh B. Pharmacokinetics of Total and Unbound Etravirine in HIV-1-Infected Pregnant Women. . 2016 11 01; 73(3):268-274. PMID: 27159225.
    23. Colón-López V, Ortiz AP, Pérez N, Acevedo E, Tamayo V, Zorrilla CD. Measuring Knowledge of Cancer Screening and Prevention Strategies in HIV Healthcare Professionals. P R Health Sci J. 2016 09; 35(3):147-53. PMID: 27623140.
      Citations: 1     Fields:    Translation:Humans
    24. Silva-Suárez G, Bastida E, Rabionet SE, Beck-Sagué C, Febo I, Zorrilla CD. "That's True Love:" Lived Experiences of Puerto Rican Perinatally HIV-Infected Youth within Their Families' Context. Int J Environ Res Public Health. 2015 Dec 22; 13(1):ijerph13010007. PMID: 26703639.
      Citations: 1     Fields:    Translation:Humans
    25. Weinberg A, Muresan P, Richardson K, Fenton T, Dominguez T, Bloom A, Watts DH, Abzug MJ, Nachman SA, Levin MJ. Heterogeneity of T Cell Responses to Pandemic pH1N1 Monovalent Vaccine in HIV-Infected Pregnant Women. AIDS Res Hum Retroviruses. 2015 Nov; 31(11):1170-7. PMID: 26322930.
      Citations:    Fields:    Translation:HumansCellsCTClinical Trials
    26. Best BM, Burchett S, Li H, Stek A, Hu C, Wang J, Hawkins E, Byroads M, Watts DH, Smith E, Fletcher CV, Capparelli EV, Mirochnick M. Pharmacokinetics of tenofovir during pregnancy and postpartum. HIV Med. 2015 Sep; 16(8):502-11. PMID: 25959631.
      Citations: 17     Fields:    Translation:HumansCells
    27. Deschamps MM, Zorrilla CD, Morgan CA, Donastorg Y, Metch B, Madenwald T, Joseph P, Severe K, Garced S, Perez M, Escamilia G, Swann E, Pape JW. Recruitment of Caribbean female commercial sex workers at high risk of HIV infection. Rev Panam Salud Publica. 2013 Aug; 34(2):92-8. PMID: 24096973.
      Citations: 7     Fields:    Translation:Humans
    28. Eley T, Huang SP, Conradie F, Zorrilla CD, Josipovic D, Botes M, Osiyemi O, Hardy H, Bertz R, McGrath D. Clinical and pharmacogenetic factors affecting neonatal bilirubinemia following atazanavir treatment of mothers during pregnancy. AIDS Res Hum Retroviruses. 2013 Oct; 29(10):1287-92. PMID: 23782005.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    29. Weinberg A, Muresan P, Fenton T, Richardson K, Dominguez T, Bloom A, Petzold E, Anthony P, Cunningham CK, Spector SA, Nachman S, Siberry GK, Handelsman E, Flynn PM. High proportions of regulatory B and T cells are associated with decreased cellular responses to pH1N1 influenza vaccine in HIV-infected children and youth (IMPAACT P1088). Hum Vaccin Immunother. 2013 May; 9(5):957-68. PMID: 23370281.
      Citations: 9     Fields:    Translation:HumansCells
    30. Zorrilla CD, Rabionet SE, Mosquera AM, Ramírez de Arellano AB. Biomedical HIV prevention strategies: state of the art and implications for public health policy in the Caribbean. P R Health Sci J. 2012 Sep; 31(3):170-9. PMID: 23038893.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    31. Jiméez J, Morales M, Castro E, Puig M, Vélez CN, Santiago L, Zorrilla C. Levels of felt stigma among a group of people with HIV in Puerto Rico. P R Health Sci J. 2012 Jun; 31(2):64-70. PMID: 22783698.
      Citations: 6     Fields:    Translation:Humans
    32. Duerr A, Huang Y, Buchbinder S, Coombs RW, Sanchez J, del Rio C, Casapia M, Santiago S, Gilbert P, Corey L, Robertson MN. Extended follow-up confirms early vaccine-enhanced risk of HIV acquisition and demonstrates waning effect over time among participants in a randomized trial of recombinant adenovirus HIV vaccine (Step Study). J Infect Dis. 2012 Jul 15; 206(2):258-66. PMID: 22561365.
      Citations: 99     Fields:    Translation:HumansCells
    33. López-Cepero R, Lynch L, Zorrilla C, Leavitt K, de la Vega A. Antenatal screening for Down syndrome with special considerations in the Puerto Rican population. P R Health Sci J. 2011 Dec; 30(4):206-10. PMID: 22263303.
      Citations:    Fields:    Translation:Humans
    34. Cohen CJ, Andrade-Villanueva J, Clotet B, Fourie J, Johnson MA, Ruxrungtham K, Wu H, Zorrilla C, Crauwels H, Rimsky LT, Vanveggel S, Boven K. Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial. Lancet. 2011 Jul 16; 378(9787):229-37. PMID: 21763935.
      Citations: 100     Fields:    Translation:HumansCellsCTClinical Trials
    35. Jiménez J, Puig M, Sala AC, Ramos JC, Castro E, Morales M, Santiago L, Zorrilla C. Felt Stigma in Injection Drug Users and Sex Workers: Focus Group Research with HIV-Risk Populations in Puerto Rico. Qual Res Psychol. 2011; 8(1):26-39. PMID: 27013930.
    36. Jimenez JC, Puig M, Ramos JC, Morales M, Asencio G, Sala AC, Castro E, Velez Santori C, Santiago L, Zorrilla C. Measuring HIV felt stigma: a culturally adapted scale targeting PLWHA in Puerto Rico. AIDS Care. 2010 Nov; 22(11):1314-22. PMID: 20665283.
      Citations: 9     Fields:    Translation:Humans
    37. Currier J, Averitt Bridge D, Hagins D, Zorrilla CD, Feinberg J, Ryan R, Falcon R, Tennenberg A, Mrus J, Squires K. Sex-based outcomes of darunavir-ritonavir therapy: a single-group trial. Ann Intern Med. 2010 Sep 21; 153(6):349-57. PMID: 20855799.
      Citations: 37     Fields:    Translation:HumansCellsCTClinical Trials
    38. Zorrilla CD, Tamayo-Agrait V. Pharmacologic and nonpharmacologic options for the management of HIV infection during pregnancy. HIV AIDS (Auckl). 2009; 1:41-53. PMID: 22096378.
    39. Rabionet SE, Santiago LE, Zorrilla CD. A multifaceted mentoring model for minority researchers to address HIV health disparities. Am J Public Health. 2009 Apr; 99 Suppl 1:S65-70. PMID: 19246663.
      Citations: 9     Fields:    Translation:Humans
    40. McElrath MJ, De Rosa SC, Moodie Z, Dubey S, Kierstead L, Janes H, Defawe OD, Carter DK, Hural J, Akondy R, Buchbinder SP, Robertson MN, Mehrotra DV, Self SG, Corey L, Shiver JW, Casimiro DR. HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis. Lancet. 2008 Nov 29; 372(9653):1894-1905. PMID: 19012957.
      Citations: 387     Fields:    Translation:HumansCells
    41. Buchbinder SP, Mehrotra DV, Duerr A, Fitzgerald DW, Mogg R, Li D, Gilbert PB, Lama JR, Marmor M, Del Rio C, McElrath MJ, Casimiro DR, Gottesdiener KM, Chodakewitz JA, Corey L, Robertson MN. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet. 2008 Nov 29; 372(9653):1881-1893. PMID: 19012954.
      Citations: 811     Fields:    Translation:HumansCellsCTClinical Trials
    42. Fätkenheuer G, Nelson M, Lazzarin A, Konourina I, Hoepelman AI, Lampiris H, Hirschel B, Tebas P, Raffi F, Trottier B, Bellos N, Saag M, Cooper DA, Westby M, Tawadrous M, Sullivan JF, Ridgway C, Dunne MW, Felstead S, Mayer H, van der Ryst E. Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection. N Engl J Med. 2008 Oct 02; 359(14):1442-55. PMID: 18832245.
      Citations: 119     Fields:    Translation:HumansCells
    43. Gulick RM, Lalezari J, Goodrich J, Clumeck N, DeJesus E, Horban A, Nadler J, Clotet B, Karlsson A, Wohlfeiler M, Montana JB, McHale M, Sullivan J, Ridgway C, Felstead S, Dunne MW, van der Ryst E, Mayer H. Maraviroc for previously treated patients with R5 HIV-1 infection. N Engl J Med. 2008 Oct 02; 359(14):1429-41. PMID: 18832244.
      Citations: 255     Fields:    Translation:HumansCellsCTClinical Trials
    44. Djomand G, Metch B, Zorrilla CD, Donastorg Y, Casapia M, Villafana T, Pape J, Figueroa P, Hansen M, Buchbinder S, Beyrer C. The HVTN protocol 903 vaccine preparedness study: lessons learned in preparation for HIV vaccine efficacy trials. . 2008 May 01; 48(1):82-9. PMID: 18391750.
    45. Chen KT, Tuomala RE, Chu C, Huang ML, Watts DH, Zorrilla CD, Paul M, Hershow R, Larussa P. No association between antepartum serologic and genital tract evidence of herpes simplex virus-2 coinfection and perinatal HIV-1 transmission. Am J Obstet Gynecol. 2008 Apr; 198(4):399.e1-5. PMID: 18177832.
      Citations: 3     Fields:    Translation:HumansCells
    46. Torres R, Hilerio CM, Silva G, Ortiz NY, Zorrilla CD, Santiago LE. Concerns about HIV and sexually transmitted infection among low-risk and high-risk women, Puerto Rico. Ethn Dis. 2008; 18(2 Suppl 2):S2-238-41. PMID: 18646357.
      Citations: 1     Fields:    Translation:Humans
    47. Zorrilla CD, Tamayo Agrait V, Febo I, Santiago LE, Díaz C, Salabarría I, Pérez E, Hillyer GV. Reduction in the perinatal HIV transmission: the experience at the Maternal Infant Studies Center and Gamma Projects at the University of Puerto Rico School of Medicine. P R Health Sci J. 2007 Dec; 26(4):329-35. PMID: 18246960.
      Citations: 3     Fields:    Translation:Humans
    48. Tremoulet AH, Capparelli EV, Patel P, Acosta EP, Luzuriaga K, Bryson Y, Wara D, Zorrilla C, Holland D, Mirochnick M. Population pharmacokinetics of lamivudine in human immunodeficiency virus-exposed and -infected infants. Antimicrob Agents Chemother. 2007 Dec; 51(12):4297-302. PMID: 17893155.
      Citations: 9     Fields:    Translation:HumansCells
    49. Zorrilla CD, Van Dyke R, Bardeguez A, Acosta EP, Smith B, Hughes MD, Huang S, Watts DH, Heckman B, Jiménez E, McSherry G, Mofenson L. Clinical response and tolerability to and safety of saquinavir with low-dose ritonavir in human immunodeficiency virus type 1-infected mothers and their infants. Antimicrob Agents Chemother. 2007 Jun; 51(6):2208-10. PMID: 17420209.
      Citations: 4     Fields:    Translation:HumansCells
    50. Zorrilla CD. HIV infection in women: perinatal issues and cervical cancer surveillance. Top HIV Med. 2007 Feb-Mar; 15(1):1-5. PMID: 17406077.
      Citations:    Fields:    Translation:HumansPHPublic Health
    51. Minkoff H, Shen X, Xian LS, Watts DH, Leighty R, Hershow R, Palefsky J, Tuomala R, Neu N, Zorrilla CD, Paul M, Strickler H. Relationship of pregnancy to human papillomavirus among human immunodeficiency virus-infected women. Obstet Gynecol. 2006 Oct; 108(4):953-60. PMID: 17012459.
      Citations: 5     Fields:    Translation:HumansCells
    52. Wojna V, Skolasky RL, Hechavarría R, Mayo R, Selnes O, McArthur JC, Meléndez LM, Maldonado E, Zorrilla CD, García H, Kraiselburd E, Nath A. Prevalence of human immunodeficiency virus-associated cognitive impairment in a group of Hispanic women at risk for neurological impairment. J Neurovirol. 2006 Oct; 12(5):356-64. PMID: 17065128.
      Citations: 52     Fields:    Translation:Humans
    53. Navas-Nacher EL, Read JS, Leighty RM, Tuomala RE, Zorrilla CD, Landesman S, Rosenblatt H, Hershow RC. Mode of delivery and postpartum HIV-1 disease progression: the Women and Infants Transmission Study. AIDS. 2006 Feb 14; 20(3):429-36. PMID: 16439877.
      Citations: 2     Fields:    Translation:HumansCells
    54. Morris AB, Dobles AR, Cu-Uvin S, Zorrilla C, Anderson J, Harwell JI, Keller J, Garb J. Protease inhibitor use in 233 pregnancies. . 2005 Sep 01; 40(1):30-3. PMID: 16123678.
    55. Tuomala RE, Watts DH, Li D, Vajaranant M, Pitt J, Hammill H, Landesman S, Zorrilla C, Thompson B. Improved obstetric outcomes and few maternal toxicities are associated with antiretroviral therapy, including highly active antiretroviral therapy during pregnancy. . 2005 Apr 01; 38(4):449-73. PMID: 15764963.
    56. Magder LS, Mofenson L, Paul ME, Zorrilla CD, Blattner WA, Tuomala RE, LaRussa P, Landesman S, Rich KC. Risk factors for in utero and intrapartum transmission of HIV. . 2005 Jan 01; 38(1):87-95. PMID: 15608531.
    57. Hilerio CM, Martínez J, Zorrilla CD, Torres R. Posttraumatic stress disorder symptoms and adherence among women living with HIV. Ethn Dis. 2005; 15(4 Suppl 5):S5-47-50. PMID: 16315382.
      Citations: 5     Fields:    Translation:Humans
    58. Zorrilla CD, Santiago LE, Hilerio C, Estronza G, Falk T. An empowerment intervention for women living with HIV and its adaptation for women with a diagnosis of breast cancer. Ethn Dis. 2005; 15(4 Suppl 5):S5-128-32. PMID: 16315392.
      Citations: 3     Fields:    Translation:Humans
    59. Thorpe LE, Frederick M, Pitt J, Cheng I, Watts DH, Buschur S, Green K, Zorrilla C, Landesman SH, Hershow RC. Effect of hard-drug use on CD4 cell percentage, HIV RNA level, and progression to AIDS-defining class C events among HIV-infected women. . 2004 Nov 01; 37(3):1423-30. PMID: 15483472.
    60. Charurat M, Blattner W, Hershow R, Buck A, Zorrilla CD, Watts DH, Paul M, Landesman S, Adeniyi-Jones S, Tuomala R. Changing trends in clinical AIDS presentations and survival among HIV-1-infected women. J Womens Health (Larchmt). 2004 Jul-Aug; 13(6):719-30. PMID: 15333287.
      Citations: 4     Fields:    Translation:Humans
    61. Acosta EP, Bardeguez A, Zorrilla CD, Van Dyke R, Hughes MD, Huang S, Pompeo L, Stek AM, Pitt J, Watts DH, Smith E, Jiménez E, Mofenson L. Pharmacokinetics of saquinavir plus low-dose ritonavir in human immunodeficiency virus-infected pregnant women. Antimicrob Agents Chemother. 2004 Feb; 48(2):430-6. PMID: 14742191.
      Citations: 28     Fields:    Translation:HumansCTClinical Trials
    62. Minkoff H, Hershow R, Watts DH, Frederick M, Cheng I, Tuomala R, Pitt J, Zorrilla CD, Hammill H, Adeniyi-Jones SK, Thompson B. The relationship of pregnancy to human immunodeficiency virus disease progression. Am J Obstet Gynecol. 2003 Aug; 189(2):552-9. PMID: 14520233.
      Citations: 11     Fields:    Translation:Humans
    63. Bardeguez AD, Shapiro DE, Mofenson LM, Coombs R, Frenkel LM, Fowler MG, Huang S, Sperling RS, Cunningham B, Gandia J, Maupin R, Zorrilla CD, Jones T, O'Sullivan MJ. Effect of cessation of zidovudine prophylaxis to reduce vertical transmission on maternal HIV disease progression and survival. . 2003 Feb 01; 32(2):170-81. PMID: 12571527.
    64. Tuomala RE, O'Driscoll PT, Bremer JW, Jennings C, Xu C, Read JS, Matzen E, Landay A, Zorrilla C, Blattner W, Charurat M, Anderson DJ. Cell-associated genital tract virus and vertical transmission of human immunodeficiency virus type 1 in antiretroviral-experienced women. J Infect Dis. 2003 Feb 01; 187(3):375-84. PMID: 12552421.
      Citations: 18     Fields:    Translation:HumansCells
    Zorrilla's Networks
    Click the
    buttons for more information and interactive visualizations!
    Concepts (275)
    Co-Authors (13)
    Similar People (60)
    Same Department Expand Description
    RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

    For technical support please contact support